G-CSF induced arteriogenesis in humans: Molecular insights into a randomized controlled trial

Current Vascular Pharmacology

Volumn 11, Issue 1, 2013, Pages 38-46

  Meier, Pascal ^a   Gloekler, Steffen ^b   Oezdemir, Berna ^c   Indermuehle, Andreas ^b   Traupe, Tobias ^b   Vogel, Rolf ^b   de Marchi, Stefano ^b   Seiler, Christian ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b PSI   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Arteriogenesis; Collateral circulation; Endothelial progenitor cells; Gene expression; Granulocyte colony stimulating factor; Monocytes

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 8; JANUS KINASE 2; PLACEBO; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; CD34 SELECTION; CELL COUNT; CELL SEPARATION; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FOLLOW UP; GENE; GENE EXPRESSION; HUMAN; ISCHEMIC HEART DISEASE; MALE; MONOCYTE; PNPLA4 GENE; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84873173253     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016113804547674     Document Type: Article

References (34)

1. Meier P, Gloekler S, Zbinden R, et al. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007; 116: 975-83.
2. Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C. The impact of the coronary collateral circulation on mortality: a metaanalysis. Eur Heart J 2011 (Epub ahead of print Oct 03, 2011)
3. Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291-7.
4. Henry TD, Annex BH, McKendall GR, et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 2003; 107: 1359-65.
5. Stewart DJ, Kutryk MJ, Fitchett D, et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN Trial. Mol Ther 2009; 17: 1109-15.
6. Schaper W. Collateral circulation: past and present. Basic Res Cardiol 2009; 104: 5-21.
7. Meier P, Gloekler S, de Marchi S, et al. Myocardial salvage through coronary collateral growth by granulocyte-colony stimulating factor in chronic coronary artery disease: a controlled randomized trial. Circulation 2009; 120: 1355-63.
8. Zbinden S, Zbinden R, Meier P, Windecker S, Seiler C. Safety and efficacy of subcutaneous-only granulocyte-macrophage colonystimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 1636-42.
9. Seiler C, Pohl T, Wustmann K, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 2001; 104: 2012-17.
10. Seiler C, Fleisch M, Garachemani A, Meier B. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol 1998; 32: 1272-9.
11. Vogel R, Zbinden R, Indermuhle A, Windecker S, Meier B, Seiler C. Collateral-flow measurements in humans by myocardial contrast echocardiography: validation of coronary pressure-derived collateral-flow assessment. Eur Heart J 2006; 27: 157-65.
12. Barnett D, Janossy G, Lubenko A, Matutes E, Newland A, Reilly JT. Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin Lab Haematol 1999; 21: 301-8.
13. Khan SS, Solomon MA, McCoy JP, Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005; 64: 1-8.
14. Oppliger Leibundgut E, Horn MP, Brunold C, et al. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases. Haematologica 2006; 91: 1465-72.
15. Meier P, Antonov J, Zbinden R, et al. Non-invasive geneexpression-based detection of well-developed collateral function in individuals with and without coronary artery disease. Heart 2009; 95: 900-8.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 2001; 25: 402-8.
17. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
18. Brunner E, Domhof S, Langer F. Non-parametric analysis of longitudinal data in factorial experiments. New York, NY: J. Wiley; 2002.
19. Hommel G. A stagewise rejective multiple test procedure based on a modified bonferroni test. Biometrika 1988; 75: 383-6.
20. R Development Core Team (2009) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, R project website (2010) http://www.R-project.org.
21. Schaper J, Konig R, Franz D, Schaper W. The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study. Virchows Arch A Pathol Anat Histol 1976; 370: 193-205.
22. Arras M, Strasser R, Mohri M, et al. Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 1998; 93: 97-107.
23. Zbinden R, Vogel R, Meier B, Seiler C. Coronary collateral flow and peripheral blood monocyte concentration in patients treated with granulocyte-macrophage colony stimulating factor. Heart 2004; 90: 945-6.
24. Bergmann CE, Hoefer IE, Meder B, et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol 2006; 80: 59-65.
25. Schirmer SH, van Nooijen FC, Piek JJ, van Royen N. Stimulation of collateral artery growth: travelling further down the road to clinical application. Heart 2009; 95: 191-7.
26. Schirmer SH, Fledderus JO, Bot PT, et al. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ Res 2008; 102: 1286-94.
27. Verstovsek S, Kantarjian H, Mesa RA, et al. Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N Engl J Med; 363: 1117-27.
28. Chen L, Iijima M, Tang M, et al. PLA2 and PI3K/PTEN pathways act in parallel to mediate chemotaxis. Dev Cell 2007; 12: 603-14.
29. Haemmerle G, Moustafa T, Woelkart G, et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPARalpha and PGC-1. Nat Med 17:1076-85.
30. Apostolakis S, Vogiatzi K, Amanatidou V, Spandidos DA. Interleukin 8 and cardiovascular disease. Cardiovasc Res 2009; 84: 353-60.
31. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97: 3422-7.
32. Ziegelhoeffer T, Fernandez B, Kostin S, et al. Bone marrowderived cells do not incorporate into the adult growing vasculature. Circ Res 2004; 94: 230-8.
33. Grajek S, Popiel M, Gil L, et al. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J 2010; 31: 691-702.
34. Deindl E, Boengler K, van Royen N, Schaper W. Differential expression of GAPDH and beta3-actin in growing collateral arteries. Mol Cell Biochem 2002; 236: 139-46.